Regulation & law · 11/04/2024

DEA Extends Temporary Schedule I Status of Butonitazene, Flunitazene, and Metodesnitazene

The Drug Enforcement Administration is temporarily extending the Schedule I status of these substances for one year, or until a permanent scheduling action is completed, through April 12, 2025.